Koios Care is a pioneering health technology company based in Antwerp, Belgium, focused on improving the quality of life for individuals with neurological and chronic conditions, starting with Parkinson’s Disease. Utilizing artificial intelligence and unobtrusive sensing, Koios Care transforms passive data from everyday smartphones and smartwatches into clinically meaningful insights. Its flagship digital health tool, Parkiwatch, passively monitors disease progression and Health-related Quality of Life (HrQoL) through digital biomarkers, enabling earlier interventions, personalized treatment, and enhanced clinical decision-making. The platform supports patients, clinicians, and pharmaceutical companies by providing real-time, objective data to optimize care and accelerate therapy development. Koios Care’s mobile and Wear OS applications collect sensor data to assess symptom frequency and severity, seamlessly integrating into daily life without added burden. The company has raised more than €1.5 million in funding aiming to expand its reach across European clinics, pursuing regulatory clearance, and forging partnerships with research and pharma sectors. With a commitment to scientific rigor and patient-centered innovation, Koios Care aims to redefine neurodegenerative care, with plans to address neuromuscular, chronic and neurodegenerative conditions in the future.